Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass ...

Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass ...

The key takeaway is that adjuvant pelvic radiotherapy after surgery can substantially improve pelvic control without causing ...

Maintaining a healthy blood sugar level can reduce your disease risk and give you more energy. These 15 habits help keep ...

Data-driven planning aids in the design of feasible clinical trials from the outset, by simulating enrollment before the ...

Nearing its 14th anniversary, Notre Dame’s Wilson Sheehan Lab for Economic Opportunity continues evaluating the impact of ...

Upending previous research, study finds no evidence of status-quo bias favoring standard care when two or more appropriate alternatives are presented.

Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

A comprehensive analysis has found no scientific evidence supporting the hypothesis that the gut microbiome causally ...

A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

The FDA has accepted the new drug application (NDA) of the synthetic, targeted radiotherapeutic agent 177 Lu-edotreotide (ITM ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...